SEARCH:   Advanced

Blood, Vol. 112, Issue 7, 2667-2674, October 1, 2008 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease Blood Flowers et al. 112: 2667 Supplemental materials for: Flowers et al Files in this Data Supplement: Table S1. Chronic GVHD characteristics for the subjects according to corticosteroid status at baseline (PDF, 14.3 KB) Table S2. Exploratory analysis (PDF, 11.8 KB) - (A) Excluding ECP corticosteroid refractory patients. (B) Excluding corticosteroid refractory patients from both treatment groups. Table S3. Response in extra-cutaneous manifestations of GVHD at Week 12 (PDF, 15.6 KB) Table S4. Response in extra-cutaneous manifestations of GVHD in the ECP treatment arm at Week 24 (PDF, 9.98 KB) Table S5. Results of targeted symptom assessment (quality of life) scored by patients1 (PDF, 13.4 KB) Figure S1. Total Skin Score (TSS) assessment* (JPG, 139 KB) - This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2010 by American Society of Hematology         Online ISSN: 1528-0020